Complications of opioids and nonsteroidal antiinflammatories in chronic nonmalignant pain

McFadzean, 1988, The ionic mechanisms underlying opioid actions, Neuropeptides, 11, 173, 10.1016/0143-4179(88)90072-8 Portenoy, 1986, Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases, Pain, 25, 171, 10.1016/0304-3959(86)90091-6 Pappagallo, 1994, Oral opioids in the management of postherapeutic neuralgia: a prospective survey, Anesth Analg, 1, 51 Zenz, 1992, Long-term oral opioid therapy in patients with chronic nonmalignant pain, J Pain Symptom Management, 7, 69, 10.1016/0885-3924(92)90116-Y Moulin, 1996, Randomised trial of oral morphine for chronic non-cancer pain, Lancet, 347, 143, 10.1016/S0140-6736(96)90339-6 Arkinstall, 1995, Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebocontrolled clinical trial, Pain, 62, 169, 10.1016/0304-3959(94)00262-D Chabal, 1992, Narcotics for chronic pain: yes or no? A useless dichotomy, APS Journal, 1, 289, 10.1016/1058-9139(92)90067-M Schofferman, 1993, Long term use of opioid analgesics for the treatment of chronic pain of non-malignant origin, J Pain Symptom Manage, 8, 279, 10.1016/0885-3924(93)90156-P Finlayson, 1986, Substance dependence and chronic pain: experience with treatment and follow up results, Pain, 26, 175, 10.1016/0304-3959(86)90073-4 Pappagallo, 1997, Ethical issues in the management of chronic non-malignant pain, 17, 203 McNairy, 1984, Prescription medication dependence and neuropsychologic function, Pain, 18, 169, 10.1016/0304-3959(84)90884-4 Rounsaville, 1981, Neuropsychological impairment in opiate addicts: risk factors, NY Acad Sci, 362, 79, 10.1111/j.1749-6632.1981.tb12795.x Appel, 1976, Digit-symbol performance in methadone-treated ex-heroin addicts, Am J Psychiatry, 133, 1337, 10.1176/ajp.133.11.1337 Lombardo, 1976, Cognitive functioning under moderate and low dose methadone maintenance, Int J Addict, 11, 389, 10.3109/10826087609056158 Hendler, 1980, A comparison of cognitive impairment due to benzodiazepines and to narcotics, Am J Psychiatry, 137, 828, 10.1176/ajp.137.7.828 Banning, 1990, Cerebral effects of long term oral opioids in cancer patients measured by continuous reaction time, Clin J Pain, 6, 91, 10.1097/00002508-199006000-00003 Sjorgen, 1989, Pain, sedation and reaction time during long term treatment of cancer patients with oral and epidural opioids, Pain, 39, 5, 10.1016/0304-3959(89)90168-1 Bruera, 1989, The cognitive effects of the administration of narcotic analgesics in patients with cancer pain, Pain, 39, 13, 10.1016/0304-3959(89)90169-3 Hill, 1963, The addiction research center inventory: standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, LSD-25, pyrahexyl and chlorpromazine, Psychopharmacologia, 4, 167, 10.1007/BF02584089 Babst, 1973 Gordon, 1976, Influence of narcotic drugs on highway safety, Acid Anal Prev, 8, 3, 10.1016/0001-4575(76)90026-9 Vainio, 1995, Driving ability in cancer patients receiving long-term morphine analgesia, Lancet, 346, 667, 10.1016/S0140-6736(95)92281-4 Rinaldi, 1988, Clarification and standardization of substance abuse terminology, JAMA, 259, 555, 10.1001/jama.1988.03720040047025 Cox, 1991, Molecular and cellular mechanisms in opioid tolerance, 137 Weissman, 1989, Opioid pseudoaddiction—an iatrogenic syndrome, Pain, 36, 363, 10.1016/0304-3959(89)90097-3 Fishbain, 1992, Drug abuse, dependence, and addiction in chronic pain patients, Clin J Pain, 8, 77, 10.1097/00002508-199206000-00003 Perry, 1982, Management of pain during debridement: a survey of US burn units, Pain, 13, 267, 10.1016/0304-3959(82)90016-1 Porter, 1980, Addiction rare in patients treated with narcotics, N Engl J Med, 302, 123, 10.1056/NEJM198001103020221 Coambs, 1996, The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within general medical practice, Pain Res Manage, 1, 155, 10.1155/1996/391248 Kreek, 1973, Medical safety and side effects of methadone in tolerant individuals, JAMA, 223, 665, 10.1001/jama.1973.03220060039009 Kreek, 1978, Medical complications in methadone patients, Ann NY Acad Sci, 311, 110, 10.1111/j.1749-6632.1978.tb16769.x Arora, 1990, Morphine induced immune alterations in vivo, Cell Immunol, 126, 343, 10.1016/0008-8749(90)90326-M Einstein, 1990, Immunosuppression to tetanus toxoid induced by implanted morphine pellets, Ann NY Acad Sci, 594, 377, 10.1111/j.1749-6632.1990.tb40501.x Molitor, 1992, Chronic morphine administration impairs cell-mediated immune responses in swine, J Pharmacol Exp Ther, 260, 581 Ling, 1985, Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms, J Pharmacol Exp Ther, 232, 149 Roth, 1996, NSAID gastropathy. A new understanding, Arch Intern Med, 156, 1623, 10.1001/archinte.1996.00440140039003 Fries, 1989, Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use, Gastroenterology, 96, 647, 10.1016/S0016-5085(89)80061-7 Cashman, 1996, The mechanisms of action of NSAIDs in analgesia, Drugs, 52, 13, 10.2165/00003495-199600525-00004 Jouzeau, 1997, Cyclo-oxygenase isoenzymes: How recent findings affect thinking about nonsteroidal anti-inflammatory drugs, Drugs, 53, 563, 10.2165/00003495-199753040-00003 Vane, 1994, Towards a better aspirin, Nature, 367, 215, 10.1038/367215a0 Hayball, 1996, Chirality and nonsteroidal anti-inflammatory drugs, Drugs, 52, 47, 10.2165/00003495-199600525-00006 Davies, 1998, Clinical pharmacokinetics of ibuproten, Clin Pharmacokinet, 34, 101, 10.2165/00003088-199834020-00002 Mandema, 1996, Population pharmacodynamic model for keterolac analgesia, Clin Pharmacol Ther, 60, 619, 10.1016/S0009-9236(96)90210-6 Lanza, 1993, Gastrointestinal toxicity of newer NSAIDs, Am J Gastroenterol, 88, 1318 Carson, 1993, Toxicity of nonsteroidal anti-inflammatory drugs. An overview of epidemiological evidence, Drugs, 46, 243, 10.2165/00003495-199300461-00063 Willett, 1994, Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs, Drug Saf, 10, 170, 10.2165/00002018-199410020-00006 Guslandi, 1997, Gastric toxicity of antiplatelet therapy with low dose aspirin, Drugs, 53, 1, 10.2165/00003495-199753010-00001 Armstrong, 1987, Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration, Gut, 28, 527, 10.1136/gut.28.5.527 Solomon, 1997, Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: Is advanced age a risk factor?, Am J Med, 102, 208, 10.1016/S0002-9343(96)00380-4 Schoen, 1989, Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage, Am J Med, 86, 449, 10.1016/0002-9343(89)90344-6 Price, 1990, Mechanisms of NSAID-induced gastroenteropathy, Drugs, 40, 1, 10.2165/00003495-199000405-00003 Henry, 1993, Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal antiinflammatory drugs, Gastroenterology, 105, 1078, 10.1016/0016-5085(93)90952-9 Gabriel, 1991, Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis, Ann Intern Med, 115, 787, 10.7326/0003-4819-115-10-787 Deykin, 1982, Ethanol potentiation of aspirin-induced prolongation of the bleeding time, N Engl J Med, 306, 852, 10.1056/NEJM198204083061406 Vane, 1995, NSAIDs, COX-2 inhibitors, and the gut, Lancet, 346, 521, 10.1016/S0140-6736(95)91378-5 Champion, 1997, NSAID-induced gastrointestinal damage—epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus, Drugs, 53, 6, 10.2165/00003495-199753010-00002 Sivarajan, 1997, Perioperative acute renal failure associated with preoperative intake of ibuprofen, Anesthesiology, 86, 1390, 10.1097/00000542-199706000-00023 Bugge, 1995, Renal effects and complications of NSAIDs for routine post-operative pain relief: increased awareness of a real problem is needed, 9, 483 Chan, 1997, Single-dose pharmacokinetics of paracetamol and its conjugates in Chinese non-insulin-dependent diabetic patients with renal impairment, Eur J Clin Pharmacol, 52, 285, 10.1007/s002280050291 Tsuboi, 1997, Acute renal failure after binge drinking of alcohol and nonsteroidal antiinflammatory drug ingestion, Intern Med, 36, 102, 10.2169/internalmedicine.36.102 Fraser, 1997, Pharmacokinetic interactions between alcohol and other drugs, Clin Pharmacokinet, 33, 79, 10.2165/00003088-199733020-00001 Camu, 1996, Side effects of NSAIDs and dosing recommendations for ketorolac, Acta Anaesthesiol Belg, 47, 143 Stichtenoth, 1996, Effects of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man, Eur J Clin Pharmacol, 51, 231, 10.1007/s002280050189 Bougie, 1997, Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia, Blood, 90, 407, 10.1182/blood.V90.1.407 Portenoy, 1994, Opioid therapy for chronic non-malignant pain: current status, 247